What we got wrong about GLP-1s
2026-04-10 · 46 min · episode 137 · 8 entities
Asserted relationships
-
0.63
evidence rules-v5
What we got wrong about GLP-1s
-
0.55
evidence rules-v5
Feed author/publisher: PJ Vogt
-
0.40
evidence rules-v5
Feed category: Business
-
0.40
evidence rules-v5
Feed category: Technology
Entities found in this episode
companys 4
-
0.50
evidence rules-v5
Feed category: Business
-
0.50
evidence rules-v5
Feed category: Technology
-
0.40
evidence rules-v5
Feed category: Business
-
0.40
evidence rules-v5
Feed category: Technology
persons 2
-
0.70
evidence rules-v5
Feed author/publisher: PJ Vogt
-
0.55
evidence rules-v5
Feed author/publisher: PJ Vogt
podcasts 1
-
0.63
evidence rules-v5
What we got wrong about GLP-1s
concepts 1
-
0.35
evidence rules-v5
GLP
Episode description as stored
Search Engine is breaking its cowardly three-year silence on GLP-1s. We have been curious about them. We have been afraid of getting in trouble. We are no longer afraid. A conversation with Dr. Rachael Bedard about the many mistakes in how the media covered these drugs and what the research shows about their surprising effects.
Dr. Bedard’s story on the rise of Ozempic
Support the show!